Baseline clinical characteristics | IPT take | Total | P-value | ||
---|---|---|---|---|---|
Yes | No | ||||
WHO C/S | One | 238(74.1) | 42(82.40) | 280 | 0.002* |
Two | 67(20.9%) | 9(17.6%) | 76 | ||
Three | 3(0.9) | 0(0.0%) | 3 | ||
Four | 13(4.0) | 0(0.0% | 13 | ||
CD4 Count | < 350 | 94(29.3%) | 14(27.5%) | 108 | 0.010* |
350–499 | 156(48.6%) | 27(152.9%) | 183 | ||
> = 500 | 71(22.1%) | 10(19.6%) | 81 | ||
BMI | < 18 | 91(28.3%) | 8(15.7%) | 99 | 0.094 |
18–25 | 216(67.3%) | 42(82.4%) | 258 | ||
> = 25 | 14(4.4%) | 1(2.0%) | 15 | ||
Hgb | < 12 mg/dl | 39(12.%) | 0(0.0) | 39 | 0.009* |
> = 12 mg/dl | 282(87.9%) | 51(100.0%) | 333 | ||
Weight | < 40 kg | 34(10.6% | 0(0.0) | 34 | 0.000* |
40–49 | 209(65.9%) | 29(56.9%) | 238 | ||
50–59 | 56(17.4%) | 21(41.2%) | 77 | ||
> 60 | 22(6.9%) | 1(2.0%) | 23 | ||
Adherence to ART med. | Good | 200(62.3%) | 34(66.7%) | 234 | 0.020* |
Fair | 80(24.9% | 17(33.3%) | 97 | ||
Poor | 41(12.8%) | 0(0.0) | 41 |